Show simple item record

dc.contributor.authorShakoori, Z
dc.contributor.authorGhanbari, H
dc.contributor.authorOmidi, Y
dc.contributor.authorPashaiasl, M
dc.contributor.authorAkbarzadeh, A
dc.contributor.authorJomeh Farsangi, Z
dc.contributor.authorRezayat, SM
dc.contributor.authorDavaran, S
dc.date.accessioned2018-08-26T07:22:01Z
dc.date.available2018-08-26T07:22:01Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/46210
dc.description.abstractMagnetic, pH and temperature-sensitive, poly(N-isopropylacrylamide) (PNIPAM)-based nanocomposites with fluorescent properties were synthesized by free radical copolymerization-cross linking of NIPAM, N,N-dimethylaminoethyl methacrylate (DMAEMA) and 4-acrylamidofluorescein (AFA). The model anti-cancer drug, cisplatin (CDDP), was loaded into the resulted nanogel. For the production of CDDP-loaded nanocomposite, Fe3O4 magnetic nanoparticles (MNPs) and CDDP were loaded into the nanogel. Field-emission scanning electron microscopy (FE-SEM) indicated that the size of nanogel and CDDP-loaded nanocomposite were about 90 and 160nm, respectively. The encapsulation efficiency of CCDP was found up to 65%. The loaded CCDP showed sustained thermal and pH-responsive drug release. A high level of drug release was observed under the conditions of low pH and high temperature. The lower critical solution temperature (LCST) of synthesized nanogel was about 40 degrees C. CDDP-loaded nanocomposite showed a volume phase transition from 282 to 128nm at its LCST. Accordingly, in this study, the synthesized nanocomposite can be employed as a stimuli-responsive anti-cancer drug delivery system and the pH and temperature of solution have the potential to monitor the drug release.
dc.language.isoEnglish
dc.relation.ispartofDRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
dc.subjectCisplatin
dc.subjectmulti-responsive magnetic nanocomposite
dc.subjectfluorescent
dc.subjectcontrolled drug delivery
dc.titleFluorescent multi-responsive cross-linked P(N-isopropylacrylamide)-based nanocomposites for cisplatin delivery
dc.typeArticle
dc.citation.volume43
dc.citation.issue8
dc.citation.spage1283
dc.citation.epage1291
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1080/03639045.2017.1313859


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record